Related by context. All words. (Click for frequent words.) 62 Pedro Lichtinger 61 James Manuso 60 Kauffman MD Ph.D. 60 Howard H. Pien 60 Kevin Buchi 60 Kathy Giusti Founder 59 Spiro Rombotis President 58 Clay Siegall 58 Mitchel Sayare 58 Georges Gemayel 57 Alessandro Riva 57 Nancy Simonian MD 57 Daniel Junius 57 Sol J. Barer 57 Dino Dina 57 Steven A. Kriegsman 57 Paolo Pucci chief 56 Mark Leuchtenberger 56 Joshua Boger 56 Matthew Emmens 56 Dani Bolognesi 56 Francois Nader 56 Zeb Horowitz 56 Joseph Feczko 56 Safi Bahcall Ph.D. 56 Lonnie Moulder 56 George Scangos 56 Frank Baldino 56 Daniel Passeri Curis 56 Mace Rothenberg senior 55 Jeffrey Buchalter 55 H. Kirn 55 Remi Barbier 55 Kemal Malik 55 commented Mitchel Sayare 55 Frank Baldino Jr. 55 Edward M. Rudnic 55 stated Belinda Tsao 55 Armando Anido 55 Tuan Ha Ngoc 55 Norbert Bischofberger 55 Eric L. Dobmeier 54 Mark HN Corrigan 54 Stanley Crooke 54 Nicole Onetto MD 54 Bassil Dahiyat Ph.D. 54 Vincent Milano ViroPharma 54 Vojo Vukovic MD Ph.D. 54 Swisher Sunesis 54 Orville G. Kolterman 54 Daniel Vasella Chairman 54 Professor Silviu Itescu 54 Mohammad Azab MD 54 Ron Bentsur 54 John Lechleiter Ph.D. 54 Christian Itin 54 Ronald Brus 54 Neil K. Warma 54 Paul Laikind 54 Jean Pierre Lehner 54 hoFH patients 54 Michael Kishbauch 54 Christopher Anzalone Arrowhead 54 Narachi 54 Steven Kriegsman 53 William Freytag 53 Mihael Polymeropoulos 53 Kevin Rakin 53 Dr. Wolfgang Wein 53 Fereydoun Firouz 53 Drew Fromkin 53 Henri A. Termeer 53 Ms. Gerri Henwood 53 Dan Passeri 53 Quay MD Ph.D. 53 Harold Van Wart 53 Scangos 53 June Almenoff MD 53 Hal Barron 53 Nancy Simonian 53 Kevin Sharer Amgen 53 Donald Drakeman 53 Paolo Paoletti MD 53 Keith Katkin AVANIR 53 Bernd Seizinger 52 Yoshihiko Hatanaka 52 Vaughn M. Kailian 52 Marc Cluzel 52 Lisa N. Drakeman 52 Alan Breier 52 Norbert Bischofberger PhD 52 Jan Turek Biolex 52 Philippe Archinard 52 Mary Tagliaferri 52 Iris Loew Friedrich 52 Ursula Ney 52 Bradbury Amylin 52 Dr. Aiping Young 52 Kathy Ordoñez Chief Executive 52 David Moskowitz GenoMed 52 Dan Passeri Curis 52 Barry Selick 52 Matt Emmens 52 Yuichi Iwaki MD Ph.D. 51 Carl A. Pelzel 51 Michael L. Kranda 51 Roger Perlmutter 51 Barry Selick Threshold 51 Orville Kolterman 51 Dr. Fahar Merchant 51 Tod Woolf Ph.D. 51 Michael H. Tardugno 51 Elmar Schnee 51 Dr. Feczko 51 Mark Pykett 51 Chang Ahn Rexahn 51 Jeffrey M. Ostrove 51 Igor Gonda 51 Murray Tekmira 51 Lorianne Masuoka MD 51 David Aviezer 51 Dr. Wayne Danter 51 intra arterial chemotherapy 51 Jorge Cortes MD 51 Dr. LaMattina 51 Richard Schilsky 51 Progenics Founder 51 Pascal Soriot 51 Ulf Wiinberg 51 Dr. Gamzu 51 Plachetka 51 Pedro Lichtinger Optimer 51 William Moffitt Nanosphere 51 James Sapirstein 51 Hoyoung Huh 51 Jim Sulat 51 Lonnel Coats President 51 Jean Paul Clozel 51 Judy C. Lewent 51 Alan Kingsman 51 Kevin Sharer 51 Masafumi Nogimori 50 Tony Bihl 50 Sol Barer 50 Joern Aldag President 50 Haim Aviv 50 Mace Rothenberg 50 Arthur Bedrosian president 50 Armando Anido Chief Executive 50 Barry D. Quart 50 Philippe Archinard Chief Executive 50 Patrick J. Balthrop 50 Yves Rosconi 50 Bruce Galton 50 Matthew Emmens Chairman 50 commented Nicholas Landekic 50 Eric Rowinsky MD 50 Alan Colowick 50 Oncology Merck Serono 50 Mark Leuchtenberger President 50 Maxine Gowen Ph.D. 50 Timothy P. Walbert 50 Ronald Krall 50 Sudhir Agrawal D.Phil 50 Jean Jacques Bienaime 50 Ph.D. Targacept 50 Dr. Marlies Sproll 50 Lloyd Malchow SenoRx 50 Paolo Paoletti 50 Sanjay Bhanot 50 Jay Lichter 50 Adelene Q. Perkins 50 Eamonn Hobbs 50 Ira L. Goldknopf 50 Strauss Noven 50 Bruce Kuhlik 50 CEO Sidney Taurel 49 Frank Morich 49 John E. Niederhuber 49 P. Roy Vagelos 49 Martyn Coombs 49 Anna Gluskin Generex 49 Roger Boissonneault 49 Prabhavathi Fernandes 49 Herbert Fritsche 49 Roger Perlmutter Amgen 49 Peter A. Lankau 49 Rob Cascella President 49 Brian JG Pereira 49 Dr. Jaap Goudsmit 49 Andreas Barner 49 anti angiogenic agents 49 Carlos Paya 49 Dr. Bruno Giannetti 49 Lars Rebien Sorensen 49 Harold H. Shlevin 49 Richard Pazdur 49 Desmond Hellmann 49 Cary Rayment 49 Vincent Mutel 49 commercialize deforolimus 49 Akshay Vaishnaw MD Ph.D. 49 Mihael Polymeropoulos MD 49 Severin Schwan 49 H. Willard Flamel 49 Ronald Brus Crucell 49 Kenneth I. Moch 49 treating neuropathic pain 49 MD FACS FAAP 49 Christoph Westphal MD Ph.D. 49 Dr. Arndt Schottelius 49 Intarcia Therapeutics 49 Bernhard Scheuble 49 Anna Gluskin 49 John Langstaff Cangene 49 Michael Narachi 49 Scott Pancoast Lpath 49 Eliezer Zomer Ph.D. 49 John C. Lechleiter 49 Steve Cartt Executive 48 Klaus Schollmeier Chief Executive 48 Tsutomu Une 48 Dr. Hassan Salari 48 Alex Lukianov 48 Eran Broshy 48 L. Berns 48 Dr. Henrich Guntermann 48 Klaus Schollmeier 48 Dr. Elliot Ehrich 48 George Perros Greystone 48 Raymond V. Gilmartin 48 Patrik De Haes 48 Friedhelm Blobel 48 Oliver Sartor 48 Steve Cartt 48 Beall Ph.D. 48 Deborah Rathjen 48 David Pernock 48 Neuro Oncology Program 48 drug Treanda 48 Roch Doliveux Chief Executive 48 Chief Executive Bernard Poussot 48 Michael V. Novinski 48 Karen Katen 48 Lamberto Andreotti 48 Wolfgang Renner 48 Dr. Karl Mettinger 48 Preclinical Development 48 Gary Dreher AMDL 48 Mr. Yves Rosconi 48 Kevin Buehler Alcon 48 Gary Guthart 48 Henrich Guntermann 48 Alexei Marko 48 John Lechleiter Lilly 48 J. Drachman 48 Alan Kessman Chief Executive 48 Dave Holveck 48 Carl Pelzel Depomed 48 Yaffa Beck 48 Goran Ando 48 Ronald W. Dollens 47 Dr. Weidong Yin 47 Deborah Dunsire 47 Mr. Frank Menzler 47 Drakeman 47 Anders Ekblom 47 Torbjörn Bjerke 47 Dr. Mace Rothenberg 47 Yvonne Greenstreet 47 Ulrich Grau Ph.D. 47 Roch Doliveux 47 DiaKine Therapeutics 47 Alexis Borisy 47 Eric von Hofe 47 Diane S. Goostree 47 Martin Madaus 47 Mendlein 47 T. Crooke 47 Belldegrun 47 M. Bradbury Amylin 47 JJ Finkelstein RegeneRx 47 colorectal lung 47 J. Donald deBethizy 47 Mads Krogsgaard Thomsen 47 Pierre Cassigneul president 47 ADVEXIN therapy 47 Dr. Richard Pazdur 47 JP Garnier 47 Pedro Granadillo 47 Levitt MD Ph.D. 47 Per Olof Wallström 47 Ph.D. XenoPort 47 Ron Bentsur Chief Executive 47 Ms. Katen 47 Garo Armen 47 Ronald Prentki 47 Flemming Ornskov 47 Richard Pazdur director 47 David Yost AmerisourceBergen 47 Argolyn 47 Kenneth Chahine 47 Ms. Lewent 47 Susan Froshauer 47 Charles Homcy MD 47 motesanib 47 Steven Galson MD MPH 47 Dr. Daniel Dosoretz 47 Michael Berelowitz 46 Jeff Morhet Chairman 46 George J. Vergis 46 Steven M. Klosk 46 Henri Termeer 46 Raafat Fahim 46 Dr. Nobuo Hanai 46 John LaMattina 46 Robert Essner 46 Gerald T. Proehl 46 Adrian Hobden 46 Prabhavathi Fernandes Ph.D. 46 monoclonal antibody therapies 46 Camillo Ricordi MD 46 Tarvacin Anti Cancer 46 Carl LeBel 46 Patricia Hartge 46 Declan Doogan 46 metastatic sarcomas 46 Avastin Tarceva 46 stated Michelle Berrey 46 Sylvie Gregoire 46 Rosty Raykov Chief Executive 46 Glenn Saldanha 46 Dr. Andreas Barner 46 Paul Bisaro Watson 46 Richard Pazdur MD 46 Michel Morre DVM 46 Moncef Slaoui 46 Anthony Giovinazzo 46 Loic Maurel 46 Shai Gozani 46 IMC #B 46 Dr. Michelle Berrey 46 Joe Feczko 46 B. Nano CTT 46 Atul Pande MD 46 Ellen Strahlman 46 Bernard Poussot 46 Phytomedics 46 Ralph Makar 46 Chief Executive Jeffrey Kindler 46 Lonny Reisman MD 46 Duane DeSisto 46 Joerg Reinhardt 46 Gearoid Faherty Chief Executive 46 Jeff Kindler 45 Stephen DeFalco 45 Rajesh Shrotriya 45 Harlan Waksal 45 Loïc Maurel MD 45 David Bupp Neoprobe 45 Dr Bernd Hentsch 45 Abiraterone acetate 45 Archexin 45 hematological malignancy 45 Evoltra ® 45 lymphomas leukemias 45 Yakatan 45 Amgen Vectibix 45 Anders Gersel Pedersen 45 Emil Kakkis MD Ph.D. 45 curative treatments 45 Panzem 45 Kirk Garratt 45 Gary Restani 45 Geert Kersten Chief Executive 45 Michele Garufi Chairman 45 Pilnik 45 David EI Pyott 45 maximally tolerated lipid lowering 45 Palmin 45 Cristofanilli 45 Gilles Gagnon 45 Somesh Sharma 45 IRX 2 45 Avastin Erbitux 45 Elizabeth G. Nabel 45 pancreatic colon 45 Dr. Kshitij Mohan 45 Hank Kucheman Executive 45 Henry McKinnell 45 Elliot Sigal 45 Steven B. Ratoff 45 thalidomide Thalomid 45 Lewent 45 Di Bisceglie 45 Lars Kongsbak 45 Greg Wujek 45 SUTENT ® 45 Alfred Sandrock MD Ph.D. 45 Joel Gemunder 45 Seewaldt 45 Breast Oncology 45 Dr. Philip Toleikis 45 Niedel 45 Sylvain Fleury 45 Dominique Limet 45 angiogenesis inhibition 45 Timo Veromaa 45 Raymond Gilmartin 45 novel immunotherapies 45 Silviu Itescu 45 prolongs survival 45 Leonard Saltz 45 Porges 45 Edwin Hemwall 45 Karl Ludwig Kley 45 Nancy Lurker 45 Steve Giordanella 45 Matthew Emmens Shire 45 Jean Francois Rossignol 45 Sidney Taurel 44 Alfred I. Neugut 44 Stephen M. Simes 44 Omar Ishrak 44 Christopher Viehbacher 44 refractory colorectal cancer 44 demonstrated antitumor activity 44 refractory ovarian cancer 44 Brandt Noven 44 TroVax ® 44 Joel Kupersmith 44 Barry Labinger 44 John McDermott Endologix 44 Gavriel Meron 44 Nora D. Volkow 44 erlotinib Tarceva 44 Dr. Olukotun 44 Rik J Deitsch 44 Dr. Ellen Strahlman 44 Derica Rice 44 Terry Copeland Altairnano 44 Barrett Toan 44 Hank McKinnell 44 Eric Ende 44 Pablo Legorreta Chief Executive 44 Shlomo Yanai Teva 44 Moise Khayrallah 44 Hans Joachim Lohrisch 44 Fibrillex 44 Roche Herceptin 44 therapeutic regimens 44 hormone refractory 44 Blane Walter 44 Michel Orsinger 44 PA Fodor 44 Panzem R 44 Steven Galson MD 44 Sanju Bansal MicroStrategy 44 NicOx commented 44 autoimmune indications 44 cardiac revascularization 44 Siegall 44 Anthony S. Fauci 44 TTF Therapy 44 Rolf Stahel 44 Shedlarz 44 Dr. Ihor Gussak 44 R. Passeri 44 Sue MacLeman 44 Dolsten 44 Carnecchia 44 BRAF V# mutation 44 Jeffrey Kindler 44 hematological cancers 44 Janet Woodcock MD 44 Pieter Muntendam MD 44 kidney urologic 44 Chief Executive Hank McKinnell 44 HCV protease inhibitors 44 multiple sclerosis psoriasis 44 Geno Germano 44 Dr. Boro Dropulic 44 Philip S. Pesin 44 Behcet uveitis 44 Michael H. Carrel 44 Vincent Renz NewCardio 44 smoldering multiple myeloma 44 Haro Hartounian 44 Sharon Hesterlee 44 Marijn Dekkers 44 metastatic renal cell 44 immunological diseases 43 Arnold Hantman 43 Janet Greeson 43 John A. Kraeutler 43 Tachi Yamada 43 ganetespib 43 Spiro Rombotis 43 Carl Feldbaum 43 Charlotte Keywood 43 Molowa 43 Paolo Pucci 43 allogenic stem cell 43 immune dysregulation 43 Raymund Breu 43 malignant pheochromocytoma 43 Allovectin 7 ® 43 Per Olof Andersson 43 Cowan Cannabis Science 43 Al Altomari 43 Fred Eshelman PPD 43 Bioenvision compounds under 43 immunotherapeutic approaches 43 Mr. Zuerblis 43 P. Koestler Ph.D. 43 FluCide 43 Hervé Hoppenot President 43 Andrin Oswald 43 Pieter Muntendam 43 Ray Salemme 43 Pernock 43 AJ Kazimi Chief Executive 43 David E. Kandzari 43 Thomas Ramdahl 43 Jeffrey Shuren 43 Jim Musick Vitro 43 refractory Hodgkin 43 indolent NHL 43 Stephen Huhn 43 Teverelix 43 Jon LeCroy 43 thetreatment 43 J. Barberich 43 G. Wiggans 43 Mossinghoff 43 JJ Finkelstein 43 Jean Michel Halfon 43 ThromboGenics commenting 43 Dr. Gail Cawkwell 43 FOLFOX chemotherapy 43 A. Viehbacher 43 Howard Fillit MD 43 samalizumab 43 uric acid lowering 43 paclitaxel Taxol ® 43 CYT# potent vascular disrupting 43 Kenneth Olden 43 Gregg Zank 43 atrial arrhythmias 43 Evoltra TM 43 Thase 43 stated Barry Polisky 43 Richard Nottenburg 43 Daniel O. Wilds 43 Harry Yanowitz 43 investigational therapies 43 Jorkasky 43 OnDose TM 43 Juergen Engel 43 Dr. Debra Birnkrant 43 Lawrence Siebert Chembio 43 Gary Nabel MD 43 Xu Hang Mindray 43 Bioaccelerate compounds under 43 Anthony DiTonno 43 Craig Tuttle Transgenomic 43 CCR9 antagonist 43 Daniel Vasella 42 Funtleyder 42 Zhi Hong 42 Dirk Kuyper 42 Aharon Schwartz 42 Laurence Birch DATATRAK 42 MGN# 42 refractory metastatic 42 radiation chemoradiation 42 J. Vander Zanden 42 investigational monoclonal antibody 42 anticancer therapies 42 Jim DeMesa 42 Sandra Kweder 42 Trudy Sullivan 42 immune modulating 42 Hank Krakowski poses 42 Dr. Vitetta 42 gastrointestinal mucositis 42 systemic mastocytosis 42 Malcolm Skolnick CytoGenix 42 Provecta 42 Troxatyl 42 Trevor Mundel MD 42 Nitric Bio 42 Dr. Karl Johe 42 pain palliation 42 antirejection 42 Elazar Rabbani 42 AstraZeneca Iressa 42 John Hammergren 42 dasatinib Sprycel 42 Lilly Alimta 42 Alimta pemetrexed 42 Taurel 42 lupus multiple sclerosis 42 Campos Outcalt 42 chemotherapy hormonal therapy 42 Surgical resection 42 Rummelt 42 Christine Poon 42 molecularly targeted therapies 42 antiangiogenesis therapies 42 induce remission 42 relapsed SCLC 42 vaccines oncolytic virus 42 Sigurdur Oli Olafsson 42 allogeneic HSCT 42 Mott MedImmune 42 Brian Markison 42 Gino Santini 42 XL# SAR# 42 Oncology Drug 42 Tom Freyman 42 EnVivo 42 leukemia multiple myeloma 42 liver metastasis 42 Erion Ph.D. 42 Boaz Raviv Chief Executive 42 axitinib 42 Scott Tarriff 42 Robert C. Arzbaecher 42 Robert J. Broeze 42 Ofer Haviv Evogene 42 advanced HER2 positive 42 R.Ph 42 Michael Seepersaud 42 stated Giovanni Recordati 42 Patrick Fourteau Chief Executive 42 dalbavancin 42 Gleevec resistant 42 Dr. Steve Pakola 42 Dr. Deepa Subramaniam 42 Jeffrey B. Kindler 42 Carl Casale 42 Ben Shappley 42 J. Coury 42 pharmacologic therapies 42 Gemunder 42 Hubertus Erlen 42 uncontrolled epilepsy 42 recurrent glioblastoma 42 nonmyeloablative 42 torsemide ER 42 Mr. Pilnik 42 immunosuppressive medication 42 Laurence Debroux 42 Chemophase 42 A. Leerink 42 standard chemotherapy regimens 42 Simeonidis 42 paclitaxel poliglumex 42 therapies 41 Inhaled insulin 41 Lung transplantation 41 Schenkein 41 ELACYT 41 André Michel Ballester 41 anidulafungin 41 Zami Aberman Pluristem 41 Bezielle 41 Dr. Daniel Zurr 41 Kinase inhibitors 41 Inflammatory diseases 41 obatoclax 41 Plohoros 41 Samuel Strober 41 immunosuppressive therapies 41 Web Golinkin 41 Gearoid Faherty Chairman 41 Eli Hurvitz 41 treat enlarged prostate 41 Leuchtenberger 41 Butchofsky 41 Smac mimetics 41 Diane Bieri 41 hematological malignancies 41 Jesse Blout San Francisco 41 Dr. Tina Sampalis 41 Bruce Cranna 41 Czirr 41 relapsed refractory aggressive 41 antiangiogenic agents 41 DCVax R 41 Clozel 41 Soiffer 41 Feczko 41 Vidaza azacitidine 41 refractory acute myeloid 41 Alan Shortall Chief Executive 41 ovarian lung 41 Eric Stonestrom Airspan 41 Arthur S. Przybyl 41 Enoch Jen 41 neovascular diseases 41 Biogen 41 Svein Lien 41 Cerimon Pharmaceuticals 41 cytoreduction 41 ceoforum.com.au What 41 Gemin X. 41 metastatic colorectal 41 Chris Viehbacher 41 relapsed ovarian cancer 41 Stan Yakatan 41 Bob Iannucci 41 Chronic pancreatitis 41 Masayo Tada 41 Dr. Zhongyi Liu 41 Zemiva TM 41 medically inoperable 41 mTOR inhibitors 41 castration resistant hormone refractory 41 Susan B. Shurin 41 Ms. Stancic 41 Novartis AG Gleevec 41 Darretta 41 Dominic Caruso 41 endocrine therapies 41 BRAF inhibitors 41 Frank D' Amelio 41 Peter Nowacki DIAGNOS 41 MD FACC FSCAI 41 John Aglialoro CYBEX 41 Charles T. Saldarini 41 Perforomist ™ Inhalation Solution 41 TransVax 41 Patricia O'Looney 41 ZOLINZA 41 lupus nephritis 41 Ivan Gergel MD 41 Jesper Brandgaard 41 BZL# 41 M. Blondy 41 Richardson MRCP 41 relapsed leukemia 41 Autoimmune diseases 41 oxymorphone ER 41 Her2 positive 41 HealthCor 41 Lisofylline 41 Robert H. Benmosche 41 hematological disorders 41 Strumph 41 gastroenterology neurology 41 hematopoietic malignancies 41 Dr. Declan Doogan 41 transplantation HCT 41 pertuzumab 41 Rachel Ballard Barbash 40 andChief Executive Officer 40 Hepatocellular Carcinoma HCC 40 squamous non 40 Heeschen 40 MAXY G# 40 blood clot dissolving 40 Bevacizumab Avastin 40 CMV disease 40 Rituxan rituximab 40 Spokeswoman Amy Cianciaruso 40 Emilio Emini Ph.D. 40 Chas Radovich 40 steroid refractory GvHD 40 immuno modulatory 40 treating sarcoma testicular 40 Erich Reinhardt 40 Blissenbach 40 Len Lichtenfeld MD 40 Ulrich Dauer CEO 40 Andreas Rummelt 40 HQK 40 J. Melamede 40 Patrick Fourteau 40 CEO Hubertus Erlen 40 Eric Winer 40 diabetic kidney 40 Glioblastoma Multiforme GBM 40 Uma Chowdhry 40 Kidney transplantation 40 Edward H. Bersoff 40 squamous cell lung cancer 40 Richard Trevillion 40 TwinCaps R 40 oral clodronate 40 Riluzole 40 Tardugno 40 oncologic 40 fibrate drugs 40 preventing recurrences 40 Cummins Cyberonics 40 Cancer Immunobiology Center 40 heavily pretreated 40 signal transduction inhibitors 40 immuno inflammatory 40 Glen Tullman Chief Executive 40 Koziarz 40 Kevin De Cock 40 Shlomo Yanai 40 metastatic kidney 40 Raghu Kilambi 40 imatinib Gleevec ® 40 Richard Bergenstal MD 40 opioid tolerant adult 40 Carlo Montagner 40 Kelly Mann Mediware 40 therapeutic armamentarium 40 sorafenib Nexavar 40 myelofibrosis 40 immunosuppressive regimens 40 oral anticancer 40 LE DT 40 stated Gil Allon 40 CEO Jeffrey Kindler 40 treating cancerous tumors 40 Jami Rubin 40 Harvey TenFold 40 Liver transplantation 40 cyclophosphamide chemotherapy 40 imatinib Gleevec 40 antiplatelet therapies 40 evaluating picoplatin 40 forodesine 40 thoracoscopic lobectomy 40 Karel Reisz suffered 40 lowering blood glucose 40 neuroprotective therapies 40 R. Luber 40 cirrhosis liver failure 40 brain tumor glioblastoma multiforme 40 radiation therapy SBRT 40 ZACTIMA TM ZD# 40 Andrew Witty 40 resistant hormone refractory 40 Excaliard Pharmaceuticals 40 Dr. Frank Vocci 40 Kishbauch 40 Vandetanib 40 receiving chemoradiation therapy 40 Peer Schatz Chief Executive 40 Noxafil 40 colorectal cancer liver metastases 40 George W. LeMaitre 40 oxaliplatin Eloxatin 40 TNFerade TM 40 Tectin TM 40 Terry Dwelle 40 XP# XP# 40 androgen ablation 40 Jean Pierre Garnier 40 Cell Lymphoma CTCL 40 Aberman 40 M. Perlmutter 40 curative therapies 40 Lechleiter 40 metastatic uveal melanoma 40 Ishrak 40 abiraterone 40 Bob Nosal Halton 40 TTR amyloidosis 40 Chief Executive Sidney Taurel 40 Stefan Zeuzem MD 40 Chief Executive Raymond Gilmartin 40 colorectal ovarian 40 Dr. Bernhard Kirschbaum 40 Donna Ambrosino 40 palliative radiotherapy 39 J. Coury Mylan 39 heterozygous FH 39 osteoarthritic pain 39 CINTREDEKIN BESUDOTOX 39 ORENCIA R 39 Robert Stempel 39 standard chemotherapy regimen 39 DeRubeis 39 Damien Conover 39 Immunotherapeutic 39 Chris Viehbacher Sanofi 39 R0 resection 39 Roy Vagelos 39 Amar Sawhney 39 curable cancers 39 Combivir Kivexa 39 Hugues de Bantel 39 Aggrastat ® tirofiban hydrochloride 39 Zieziula 39 Jevtana 39 Poussot 39 Keltjens 39 W. Cremin Esterline 39 Glioblastoma multiforme GBM 39 myelogenous leukemia 39 pharmacological treatments 39 tolerability profiles 39 treatment regimens 39 Enyedy 39 aromatase inhibitors AIs 39 NHLBI Acting 39 W. Baxter MAusIMM 39 steroid refractory 39 Chief Exective 39 postoperative chemotherapy 39 Bruno Tocque 39 Kenneth Kornman 39 advanced hepatocellular carcinoma 39 neuroendocrine cancers 39 Branislav Vajdic Ph.D. 39 Chronic lymphocytic leukemia 39 targets TRPM8 39 TNF blocker therapy 39 Immunosuppressive 39 Richard Montoni Chief Executive 39 ICD therapy 39 Jansen Kraemer 39 cardiothoracic transplant 39 Ken Sagoe 39 Nothing Wadden 39 vascular anatomy 39 hormonally responsive 39 postoperative pulmonary 39 Acute Radiation Syndrome ARS 39 Aurora Biosciences 39 haematologic malignancies 39 Christian Jourquin 39 Prof. Desire Collen 39 CEO Hank McKinnell 39 Bristol Myers 39 lipid lowering therapies 39 adalimumab Humira 39 hematological diseases 39 de novo kidney transplant 39 Ray Kerins 39 LPLD 39 thymic carcinoma 39 HER2 positive breast 39 curative therapy 39 impair fertility 39 cardiac allograft vasculopathy 39 Jacqueline Kosecoff 39 pemphigus vulgaris 39 Stanicky 39 pancreatic islet cell 39 anticancer treatments 39 Wolfgang Plischke 39 figitumumab 39 Dr. Karen Midthun 39 Wherry Ph.D. 39 MabThera Rituxan 39 Saftlas 39 LEE Jong wook 39 debilitating complication 39 surgically resectable 39 pharmacologic intervention 39 D. Maves 39 pancreatic lung 39 antithrombotic therapy 39 Firestein 39 Viktor Rozsnyay 39 Weizhou Lian Chief Executive 39 myeloablative 39 cilengitide 39 Jack Bovender 39 gastrointestinal stromal tumor GIST 39 Temodar ® 39 immunosuppression therapy 39 Robert J. Daretta 39 Keusch 39 JP Borneman 39 recurrent metastatic ovarian cancer 39 PKCi 39 Squamous cell 39 Larry Washow AMCOL 39 DeComo 39 anti angiogenic therapy 39 lymphoma leukemia 39 Roxana Mehran MD 39 Bernd Schulte 39 Tananbaum 39 Laurent Condomine 39 molecularly targeted 39 Peter Vitulli 39 Pratik Shah 39 Corneal transplants 39 Temporal lobe epilepsy 38 fulvestrant 38 Kuhlik 38 NEUMUNE 38 Leo Berlinghieri Chief Executive 38 Michel Kazatchkine Executive 38 lenalidomide dexamethasone 38 recurrent metastatic 38 H. Benmosche AIG 38 executive Aidan Heavey